Back
Nektar Therapeutics Stock Price Chart
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
73
NKTR
Nektar Therapeutics
Last Price:
$56.00
Seasonality Move:
1.26%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.62 | Buy |
| 20-day SMA: | 37.79 | Buy |
| 50-day SMA: | 44.49 | Buy |
| 200-day SMA: | 36.46 | Buy |
| 8-day EMA: | 41.21 | Buy |
| 20-day EMA: | 39.83 | Buy |
| 50-day EMA: | 43.18 | Buy |
| 200-day EMA: | 38.72 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 73.32 | Buy |
| Chaikin Money Flow: | 7356254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.33 - 42.65) | Buy |
| Bollinger Bands (100): | (42.15 - 60.93) | Buy |
Nektar Therapeutics Technical Analysis
| Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 56.00 while NKTR 8-day simple moving average is 39.62, which is a Buy signal.
-
The stock price of NKTR is 56.00 while Nektar Therapeutics 20-day SMA is 37.79, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 44.49 while NKTR share price is 56.00, making it a Buy technically.
-
NKTR stock price is 56.00 and Nektar Therapeutics 200-day simple moving average is 36.46, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
73
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $56.00. The Score for NKTR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
968.8M
Price in USD:
56.00
Share Volume:
8.7M
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Buy
73
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 56.00 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 56.00 while NKTR 8-day exponential moving average is 41.21, which is a Buy signal.
-
The stock price of NKTR is 56.00 while Nektar Therapeutics 20-day EMA is 39.83, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 43.18 while NKTR share price is 56.00, making it a Buy technically.
-
NKTR stock price is 56.00 and Nektar Therapeutics 200-day simple moving average is 38.72, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.08 per share, and a decrease next year of $2.48 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 73.32, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (34.33 - 42.65), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (42.15 - 60.93), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.